K

K36 Therapeutics, Inc.

8 employees

K36 Therapeutics translate epigenetic modulation of oncogenic pathways into small molecule therapies.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics

Date founded

2021

Funding rounds raised

Total raised

$70M

from 6 investors over 6 rounds

K

K36 Therapeutics, Inc. raised $70M on June 28, 2023

Investors: Nextech Invest, Bristol-Myers Squibb, UK, Atlas Venture and F-Prime Capital Partners

K

K36 Therapeutics, Inc. raised $30M on December 9, 2021

Investors: F-Prime Capital Partners and Atlas Venture

FAQ